60373-71-9 Usage
General Description
1-(1-Benzyl-1,2,3,6-tetrahydro-pyridin-4-yl)-1,3-dihydro-benzoimidazol-2-one is a chemical compound that belongs to the class of benzimidazole derivatives. It is a synthetic organic compound that has potential pharmaceutical applications. The compound contains a benzene ring attached to a pyridine ring, and it also contains a benzimidazole ring. These structural features make it a potentially important compound for medicinal chemistry research. The compound may have biological activities such as enzyme inhibition or receptor modulation, and further research is needed to fully understand its potential uses in the field of pharmacology.
Check Digit Verification of cas no
The CAS Registry Mumber 60373-71-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,3,7 and 3 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 60373-71:
(7*6)+(6*0)+(5*3)+(4*7)+(3*3)+(2*7)+(1*1)=109
109 % 10 = 9
So 60373-71-9 is a valid CAS Registry Number.
InChI:InChI=1/C19H19N3O/c23-19-20-17-8-4-5-9-18(17)22(19)16-10-12-21(13-11-16)14-15-6-2-1-3-7-15/h1-10H,11-14H2,(H,20,23)
60373-71-9Relevant articles and documents
Rearrangement of spiro-benzimidazolines: preparation of N-alkenyl- and N-alkyl-benzimidazol-2-ones
Kuethe, Jeffrey T.,Varon, Jack,Childers, Karla G.
, p. 11489 - 11502 (2008/03/13)
A synthetically useful protocol has been developed for the preparation of highly functionalized N-alkenyl-benzimidazol-2-ones. Reaction of commercially available o-phenylenediamines with variously substituted cyclic ketones provides spiro-benzimidazolines. Treatment of these spiro-benzimidazolines with triphosgene in the presence of potassium carbonate results in rapid rearrangement and formation of N-alkenyl-benzimidazol-2-ones in modest to excellent yield for the two-step sequence. Extension of this methodology toward the preparation of a μ opiate receptor antagonist and droperidol, a potent antiemetic and antipsychotic agent, currently a marketed pharmaceutical is also described. Upon treatment of spiro-benzimidazolines with triphosgene in the presence of sodium triacetoxyborohydride, N-alkyl-benzimidazol-2-ones were formed.